Switch to:
Also traded in: Delisted, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.05
PAH's Cash-to-Debt is ranked lower than
90% of the 1122 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.72 vs. PAH: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
PAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.08 Max: 0.86
Current: 0.05
0.05
0.86
Equity-to-Asset 0.22
PAH's Equity-to-Asset is ranked lower than
92% of the 1092 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.57 vs. PAH: 0.22 )
Ranked among companies with meaningful Equity-to-Asset only.
PAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.27 Max: 0.55
Current: 0.22
0.21
0.55
Debt-to-Equity 2.63
PAH's Debt-to-Equity is ranked lower than
95% of the 931 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.39 vs. PAH: 2.63 )
Ranked among companies with meaningful Debt-to-Equity only.
PAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.49  Med: 1.88 Max: 2.64
Current: 2.63
0.49
2.64
Debt-to-EBITDA 7.89
PAH's Debt-to-EBITDA is ranked lower than
93% of the 913 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.12 vs. PAH: 7.89 )
Ranked among companies with meaningful Debt-to-EBITDA only.
PAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.44  Med: 13.47 Max: 16.75
Current: 7.89
4.44
16.75
Interest Coverage 1.60
PAH's Interest Coverage is ranked lower than
96% of the 1021 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 29.84 vs. PAH: 1.60 )
Ranked among companies with meaningful Interest Coverage only.
PAH' s Interest Coverage Range Over the Past 10 Years
Min: 0.25  Med: 0.93 Max: 2.35
Current: 1.6
0.25
2.35
Piotroski F-Score: 4
Altman Z-Score: 0.87
Beneish M-Score: -2.97
WACC vs ROIC
13.88%
8.60%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % 10.58
PAH's Operating Margin % is ranked higher than
60% of the 1107 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.34 vs. PAH: 10.58 )
Ranked among companies with meaningful Operating Margin % only.
PAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.13  Med: 8.09 Max: 15.78
Current: 10.58
1.13
15.78
Net Margin % -10.31
PAH's Net Margin % is ranked lower than
90% of the 1106 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.82 vs. PAH: -10.31 )
Ranked among companies with meaningful Net Margin % only.
PAH' s Net Margin % Range Over the Past 10 Years
Min: -12.14  Med: -2.81 Max: 6.29
Current: -10.31
-12.14
6.29
ROE % -19.17
PAH's ROE % is ranked lower than
91% of the 1107 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.43 vs. PAH: -19.17 )
Ranked among companies with meaningful ROE % only.
PAH' s ROE % Range Over the Past 10 Years
Min: -19.17  Med: -10.81 Max: 1.03
Current: -19.17
-19.17
1.03
ROA % -4.95
PAH's ROA % is ranked lower than
88% of the 1134 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.78 vs. PAH: -4.95 )
Ranked among companies with meaningful ROA % only.
PAH' s ROA % Range Over the Past 10 Years
Min: -4.95  Med: -0.88 Max: 7.46
Current: -4.95
-4.95
7.46
ROC (Joel Greenblatt) % 19.08
PAH's ROC (Joel Greenblatt) % is ranked lower than
53% of the 1130 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.65 vs. PAH: 19.08 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1.34  Med: 4.37 Max: 104.33
Current: 19.08
-1.34
104.33
3-Year Revenue Growth Rate 28.40
PAH's 3-Year Revenue Growth Rate is ranked higher than
94% of the 1052 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. PAH: 28.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.95 Max: 28.4
Current: 28.4
0
28.4
3-Year EBITDA Growth Rate 26.50
PAH's 3-Year EBITDA Growth Rate is ranked higher than
81% of the 980 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.60 vs. PAH: 26.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -11.75 Max: 26.5
Current: 26.5
0
26.5
3-Year EPS without NRI Growth Rate 18.80
PAH's 3-Year EPS without NRI Growth Rate is ranked higher than
62% of the 904 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.10 vs. PAH: 18.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.8
Current: 18.8
0
18.8
GuruFocus has detected 2 Warning Signs with Platform Specialty Products Corp PAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PAH's 30-Y Financials

Financials (Next Earnings Date: 2019-02-28 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

PAH Guru Trades in Q3 2017

Larry Robbins 14,328,633 sh (+8.52%)
Mario Gabelli 65,000 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Chuck Royce 92,200 sh (-3.96%)
Murray Stahl 587,157 sh (-5.11%)
Jim Simons 692,699 sh (-11.55%)
John Griffin 9,335,000 sh (-12.85%)
Paul Tudor Jones 661,925 sh (-22.32%)
Joel Greenblatt 15,530 sh (-86.02%)
» More
Q4 2017

PAH Guru Trades in Q4 2017

Chuck Royce 720,108 sh (+681.03%)
Jim Simons 1,675,300 sh (+141.85%)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Larry Robbins 14,328,633 sh (unchged)
Mario Gabelli 65,000 sh (unchged)
Joel Greenblatt Sold Out
John Griffin Sold Out
Murray Stahl 491,508 sh (-16.29%)
Paul Tudor Jones 160,510 sh (-75.75%)
» More
Q1 2018

PAH Guru Trades in Q1 2018

Joel Greenblatt 21,746 sh (New)
David Tepper 3,798,055 sh (New)
Paul Tudor Jones 281,008 sh (+75.07%)
Chuck Royce 720,108 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Mario Gabelli 65,000 sh (unchged)
Murray Stahl 483,163 sh (-1.70%)
Larry Robbins 13,411,427 sh (-6.40%)
Jim Simons 19,700 sh (-98.82%)
» More
Q2 2018

PAH Guru Trades in Q2 2018

Jim Simons 504,200 sh (+2459.39%)
Mario Gabelli 111,000 sh (+70.77%)
David Tepper 4,338,801 sh (+14.24%)
Chuck Royce 820,108 sh (+13.89%)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Murray Stahl 470,446 sh (-2.63%)
Larry Robbins 12,494,222 sh (-6.84%)
Paul Tudor Jones 244,498 sh (-12.99%)
Joel Greenblatt 18,194 sh (-16.33%)
» More
» Details

Insider Trades

Latest Guru Trades with PAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325998    SIC: 2899
Compare:NYSE:SXT, NYSE:KRO, LSE:VCT, SZSE:002648, SHSE:600873, BOM:500870, TSE:4118, TSE:4631, NYSE:NGVT, NYSE:FUL, OSTO:HPOL B, SZSE:002709, BKK:TOA, TSE:4403, LSE:SYNT, XAMS:IMCD, NYSE:POL, NYSE:CBT, NYSE:GCP, TSE:4202 » details
Traded in other countries:PAH.Delisted, PLQ.Germany,
Headquarter Location:USA
Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Platform Specialty Products Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into two segments based on product type. The agricultural solutions segment, which generates the majority of revenue, sells fungicides, herbicides, insecticides, and seed treatments to the agriculture industry. The performance solutions segment sells chemicals used in the production of circuit boards, as well as metal and plastic finishes for the automotive and oil and gas industries. The segment also sells printing plates used for the commercial packaging of food products, boxes, and labels. More revenue is generated in the United States than any other geography.

Guru Investment Theses on Platform Specialty Products Corp

Bill Ackman Comments on Platform Specialty Products Corp - Nov 15, 2018

Platform (NYSE:PAH)’s shares increased 8% during the quarter, but are still well below the highs reached earlier this summer shortly after the company announced an agreement to sell its agricultural business to a strategic acquirer in an all-cash transaction. While management has recently reaffirmed that they remain on track to close the sale at, or shortly after, the end of the year, we believe that investors are not yet valuing Platform’s shares based upon the future earnings potential of its remaining business, Performance Solutions. We believe that few investors today are willing to consider an investment in Platform until the sale transaction closes, and the company pays down debt.

Performance Solutions is a high -quality business with a strong competitive position in secularly growing end markets which will operate with significantly less financial leverage than Platform has today. Based on analyst estimates for the remaining business, Platform’s shares trade at less than 12 times next year’s earnings, a large discount to competitors. We believe the closing of the sale will simplify Platform’s business portfolio, meaningfully reduce financial leverage, provide capacity for large share repurchases, and serve as a catalyst for future share price appreciation.

From Bill Ackman (Trades, Portfolio)'s third-quarter 2018 Pershing Square shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Aug 10, 2018

Platform Specialty Products Corporation (NYSE:PAH)

In July, Platform announced the sale of its Ag Solutions business for $4.2 billion in cash to UPL Corp. Limited, an Indian agrochemical company, a price which represents full value for the business. The transaction will significantly reduce the company’s leverage levels from six times EBITDA to less than 2.5 times and will result in a more focused business with attractive growth and cash flow characteristics. Platform also announced a $750 million share repurchase authorization (~20% of company’s current market value) conditioned upon the closing of the transaction, which it expects to occur in late 2018 or early 2019.

In August, Platform reported another quarter of strong earnings growth. Organic revenue increased 7% and organic EBITDA grew 8%. Performance Solutions organic revenue grew 5% due to broad-based growth across its regions and end markets. Organic EBITDA grew 10% due to margin expansion resulting from strong sales growth of higher margin products and cost savings from supply chain initiatives. Ag Solutions organic revenue grew 10% due to strength in the Latin and North American markets. Organic EBITDA grew 6% as margins declined due to input cost inflation that was partially offset by price increases and cost savings. Overall, Platform’s EBITDA grew 10% due to a 2% boost from foreign exchange and EPS grew 30%.

While Platform’s share price has increased ~25% this year, it still trades at a discount to the peer set in light of its high leverage and transaction uncertainty until deal closure. If Platform were to trade at a multiple that is similar to its peers after the closing of the Ag Solutions sale, the company’s shares should appreciate significantly from current levels.

From Bill Ackman (Trades, Portfolio)'s second quarter 2018 Pershing Square shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 17, 2018

Platform Specialty Products Corporation (NYSE:PAH)

Platform reported continued earnings growth this quarter as the combination of organic revenue growth, lower interest expense and a strong tailwind from foreign exchange more than offset temporary margin pressures from input cost inflation. Platform’s organic revenue grew 5% as Performance Solutions grew 4%, and Ag Solutions grew 6%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronic materials business it acquired from Alent, and overall strength in its industrial business. The growth in Ag Solutions was driven by strength in the Latin and North American markets.

Despite positive organic sales growth, Platform’s organic EBITDA decreased 3% due to input cost inflation in Ag Solutions, which the company expects to mitigate through future price increases. Performance Solutions organic EBITDA grew 2% as positive revenue growth was somewhat offset by the increased proportion of sales from lower-margin products. Ag Solutions organic EBITDA declined 8% due to input cost inflation resulting from supply shortages of key active ingredients and a higher level of sales from lower-margin products. Platform’s overall EBITDA grew 7% due to a 10% tailwind from foreign exchange. EPS increased 30% due to lower interest expense from the company’s recent debt refinancing.

On Platform’s earnings call, management reiterated that it remains on track to separate its two businesses in the second half of this year, and stated that it is evaluating various execution alternatives for the separation in order to maximize shareholder value.

From Bill Ackman (Trades, Portfolio)'s first-quarter 2018 shareholder letter.



Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform - Nov 16, 2017

Platform (NYSE:PAH)’s earnings continued to grow this quarter as growth in the Performance Solutions business offset a decline in the Ag Solutions business. Platform’s organic revenue declined 1%, as Performance Solutions grew 4% and Ag Solutions declined 5%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The decline in Ag Solutions resulted primarily from the ongoing drought in Brazil, which has caused buyers to delay their typical purchases in advance of the planting season. If the drought abates within the next few months, management believes it is likely it will recover these sales in future quarters.

Platform’s organic EBITDA increased 1%. Performance Solutions organic EBITDA grew 4% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA declined 3%, as the portion of sales from higher-margin products increased and the company continued to reduce structural costs.

Platform’s overall EBITDA grew 3% due to a 2% tailwind from foreign exchange. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 18%.

At the end of August, Platform announced that it intends to separate its Ag and Performance Solutions businesses into two publicly traded companies in order to increase long-term value. Management expects the separation to occur by the middle of next year, and is likely be effectuated by an IPO of the Ag business.


From Bill Ackman (Trades, Portfolio)'s third quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Aug 18, 2017

Platform (NYSE:PAH) reported strong earnings this quarter due to continued organic revenue growth and positive results from its ongoing cost savings initiatives. Platform’s organic revenue increased 2%, as Performance Solutions grew 6% and Ag Solutions declined 2%. The growth in the Performance Solutions segment was due primarily to the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The modest decline in Ag Solutions resulted from poor weather conditions in Eastern Europe and the restructuring of its business in Africa. Ag Solutions reported positive growth in all of its key regions outside of Eastern Europe and Africa.

Platform’s organic EBITDA increased 8% due to strong results in both segments. Performance Solutions organic EBITDA grew 7% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA grew 9% in spite of the decline in revenue due to increased sales of higher-margin products and continued cost reductions in the business.

Platform’s overall EBITDA grew 6% due to a 2% headwind from the strengthening U.S. dollar. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 25%.

From Bill Ackman (Trades, Portfolio)'s second quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 12, 2017

Platform (NYSE:PAH) reported strong earnings growth for the first quarter. The company generated organic EBITDA growth of 18%, due to revenue growth in both of its businesses and improved cost efficiencies, both at the segment and corporate level. Organic revenue growth was 3%, due to 5% organic growth in Performance Solutions and 2% organic growth in Agricultural Solutions. Performance Solutions showed particular strength this quarter in its industrial and Asian electronics segments, as its end markets have improved and the integration of Alent has helped Platform gain market share. Agricultural Solutions growth was driven by strength in Latin America, but offset somewhat by weakness in Europe due to poor weather.

Performance Solutions organic EBITDA grew 27%, due primarily to further cost synergies from the Alent acquisition and continued cost efficiencies. Agriculture Solutions organic EBITDA grew 8% due primarily to a larger sales mix of higher margin products and cost reductions related to its recently announced $100 million cost savings initiative.

In April, Platform refinanced an additional $1.9 billion of debt reducing its interest costs by 1%. Since last October, the company has refinanced more than $5 billion of debt, lowering the associated interest rate by 1% and extending the maturity on a substantial portion of its debt by three years.



From Bill Ackman (Trades, Portfolio)'s first quarter 2017 shareholder letter.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 08, 2017

2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.

From 2016 annual letter to shareholders of Pershing Square by Bill Ackman (Trades, Portfolio).

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Mar 30, 2017



2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.



From Bill Ackman (Trades, Portfolio)'s Pershing Square 2016 annual report.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Dec 09, 2016

In September, Platform (NYSE:PAH) hosted an investor day where it provided a detailed explanation of the secular growth drivers and unique competitive positioning of each of its Performance and Agricultural Solutions businesses, along with long-term guidance of 4% annual organic revenue growth and high-single digit annual EBITDA growth.

The company also announced that it had reached a revised agreement with Permira to settle its $600 million preferred stock liability related to the Arysta acquisition. Under the revised agreement, Platform has the option to pay Permira $450 million in cash and 5.5 million shares, which equates to $500 million at the current market prices and represents a savings of $100 million relative to the original agreement. To finance the cash portion of the agreement, the company raised $400 million of equity and, as a result, was able to refinance $2 billion of its debt, reducing the rate on this debt by 50 basis points and extending the maturities by three years to 2023.

At the beginning of November, Platform reported strong third quarter earnings. The company delivered 3% organic revenue growth, comprised of 4% growth in Agricultural Solutions and 2% in Performance Solutions. The results are particularly impressive given the cyclical weakness in the company’s end markets. EBITDA grew 14%, due to 5% growth before synergies and corporate costs, 6% impact from net synergies, and 3% from FX.

From Bill Ackman (Trades, Portfolio)'s Pershing Square third-quarter shareholder letter.

Check out Bill Ackman latest stock trades

Top Ranked Articles about Platform Specialty Products Corp

Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform (NYSE:PAH)’s shares increased 8% during the quarter, but are still well below the highs reached earlier this summer shortly after the company announced an agreement to sell its agricultural business to a strategic acquirer in an all-cash transaction. While management has recently reaffirmed that they remain on track to close the sale at, or shortly after, the end of the year, we believe that investors are not yet valuing Platform’s shares based upon the future earnings potential of its remaining business, Performance Solutions. We believe that few investors today are willing to consider an investment in Platform until the sale transaction closes, and the company pays down debt. Read more...
Platform Specialty Products Corporation to Present at Morgan Stanley Global Chemicals and Agriculture Conference
Platform Specialty Products Corporation Announces Date for Release of 2018 Third Quarter Financial Results
Bill Ackman Reduces Stake in Company Leading His Turnaround, Chipotle Pershing Square said it still 'loves' the stock
Pershing Square’s Bill Ackman (Trades, Portfolio) cut back on his holding of Chipotle (NYSE:CMG) this week, enjoying some profits after several difficult years. Read more...
Consolidated Research: 2018 Summary Expectations for Platform Specialty Products, Career Education, Cato, Hecla Mining, Brookdale Senior Living, and Roadrunner Transportation — Fundamental Analysis, Key Performance Indications
Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform Specialty Products Corporation (NYSE:PAH) Read more...
Platform Specialty Products Corporation Announces Date for Release of 2018 Second Quarter Financial Results
Platform Specialty Products Corporation Announces Sale of Arysta LifeScience
Platform Specialty Products Corporation Announces Corporate Name Change Following Completion of the Sale of Arysta LifeScience, Provides Pro Forma Financial Outlook and Announces Authorization for up to $750 Million in Share Repurchases
Platform Enters Exclusive Negotiations with Prospective Acquirer of Arysta LifeScience

Ratios

vs
industry
vs
history
Forward PE Ratio 12.69
PAH's Forward PE Ratio is ranked higher than
70% of the 114 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.29 vs. PAH: 12.69 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 1.61
PAH's PB Ratio is ranked higher than
61% of the 1099 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.83 vs. PAH: 1.61 )
Ranked among companies with meaningful PB Ratio only.
PAH' s PB Ratio Range Over the Past 10 Years
Min: 0.65  Med: 1.33 Max: 2.71
Current: 1.61
0.65
2.71
PS Ratio 0.68
PAH's PS Ratio is ranked higher than
64% of the 1085 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.27 vs. PAH: 0.68 )
Ranked among companies with meaningful PS Ratio only.
PAH' s PS Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1 Max: 8.72
Current: 0.68
0.48
8.72
Price-to-Operating-Cash-Flow 63.33
PAH's Price-to-Operating-Cash-Flow is ranked lower than
80% of the 602 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.12 vs. PAH: 63.33 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.86  Med: 20.24 Max: 71.39
Current: 63.33
3.86
71.39
EV-to-EBIT 32.43
PAH's EV-to-EBIT is ranked lower than
90% of the 986 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.73 vs. PAH: 32.43 )
Ranked among companies with meaningful EV-to-EBIT only.
PAH' s EV-to-EBIT Range Over the Past 10 Years
Min: -7489.8  Med: 39.1 Max: 1143.1
Current: 32.43
-7489.8
1143.1
EV-to-EBITDA 12.43
PAH's EV-to-EBITDA is ranked lower than
65% of the 1002 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.50 vs. PAH: 12.43 )
Ranked among companies with meaningful EV-to-EBITDA only.
PAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.2  Med: 26 Max: 774.9
Current: 12.43
10.2
774.9
EV-to-Revenue 1.75
PAH's EV-to-Revenue is ranked lower than
66% of the 1098 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.45 vs. PAH: 1.75 )
Ranked among companies with meaningful EV-to-Revenue only.
PAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.7  Med: 2.6 Max: 10.1
Current: 1.75
1.7
10.1
Current Ratio 2.19
PAH's Current Ratio is ranked higher than
58% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.90 vs. PAH: 2.19 )
Ranked among companies with meaningful Current Ratio only.
PAH' s Current Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.11 Max: 7.71
Current: 2.19
1.66
7.71
Quick Ratio 2.00
PAH's Quick Ratio is ranked higher than
59% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.37 vs. PAH: 2.00 )
Ranked among companies with meaningful Quick Ratio only.
PAH' s Quick Ratio Range Over the Past 10 Years
Min: 1.3  Med: 1.65 Max: 7.02
Current: 2
1.3
7.02
Days Inventory 63.13
PAH's Days Inventory is ranked lower than
70% of the 1075 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 64.18 vs. PAH: 63.13 )
Ranked among companies with meaningful Days Inventory only.
PAH' s Days Inventory Range Over the Past 10 Years
Min: 36.92  Med: 79.12 Max: 120.71
Current: 63.13
36.92
120.71
Days Sales Outstanding 30.06
PAH's Days Sales Outstanding is ranked lower than
85% of the 1082 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 68.33 vs. PAH: 30.06 )
Ranked among companies with meaningful Days Sales Outstanding only.
PAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.06  Med: 111.75 Max: 146.87
Current: 30.06
30.06
146.87
Days Payable 14.50
PAH's Days Payable is ranked higher than
66% of the 1061 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 56.72 vs. PAH: 14.50 )
Ranked among companies with meaningful Days Payable only.
PAH' s Days Payable Range Over the Past 10 Years
Min: 14.5  Med: 77.08 Max: 106.01
Current: 14.5
14.5
106.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -16.40
PAH's 3-Year Average Share Buyback Ratio is ranked lower than
86% of the 627 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -3.80 vs. PAH: -16.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40  Med: -32.3 Max: -16.4
Current: -16.4
-40
-16.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.29
PAH's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 622 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.43 vs. PAH: 1.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.2  Med: 1.31 Max: 1.41
Current: 1.29
1.2
1.41
Price-to-Median-PS-Value 0.69
PAH's Price-to-Median-PS-Value is ranked higher than
64% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.08 vs. PAH: 0.69 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.56  Med: 1.02 Max: 8.81
Current: 0.69
0.56
8.81
Earnings Yield (Greenblatt) % 3.08
PAH's Earnings Yield (Greenblatt) % is ranked lower than
79% of the 1133 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.92 vs. PAH: 3.08 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1.1  Med: 1.4 Max: 5
Current: 3.08
-1.1
5
Forward Rate of Return (Yacktman) % 24.33
PAH's Forward Rate of Return (Yacktman) % is ranked higher than
95% of the 702 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.68 vs. PAH: 24.33 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 23.7  Med: 24.1 Max: 24.6
Current: 24.33
23.7
24.6

More Statistics

Revenue (TTM) (Mil) $4,861.00
EPS (TTM) $ -1.75
Beta3.30
Volatility37.38%
52-Week Range $9.09 - 13.54
Shares Outstanding (Mil)287.39

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 2,985 2,755 2,143
EBIT (Mil $) 662 628 482
EBITDA (Mil $) 764 706 520
EPS ($) 0.65 0.90 1.14
EPS without NRI ($) 0.65 0.90 1.14
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}